Tehran University of Medical Sciences

Science Communicator Platform

Share By
Impact of Change, Fluctuation, or Variability in Weight on the Risk of Nonalcoholic Fatty Liver Disease in General Population: A Systematic Review and Meta-Analysis Publisher



Alijanzadeh D ; Noroozi M ; Rostami N ; Norouzkhani N ; Shojaei Baghini M ; Lashkajani SZ ; Mirzaei A ; Dianati M ; Salimi M ; Sadeghsalehi H ; Jadidian F ; Ghane Ezabadi S ; Fallahi MS ; Fathi M Show All Authors
Authors
  1. Alijanzadeh D
  2. Noroozi M
  3. Rostami N
  4. Norouzkhani N
  5. Shojaei Baghini M
  6. Lashkajani SZ
  7. Mirzaei A
  8. Dianati M
  9. Salimi M
  10. Sadeghsalehi H
  11. Jadidian F
  12. Ghane Ezabadi S
  13. Fallahi MS
  14. Fathi M
  15. Alizadeh A
  16. Asadi Anar M
  17. Deravi N

Source: Health Science Reports Published:2025


Abstract

Background and Aim: Numerous studies on the impact of weight changes on nonalcoholic fatty liver disease are being conducted; therefore, this systematic review aims to critically discuss the impact of change, fluctuation, or variability in weight on the risk of nonalcoholic fatty liver disease in the general population. Methods: Data from three databases, PubMed/Medline, Google Scholar, and Scopus, which were available until June 2024, were used to compile the materials for our research. Only English-language publications were submitted for this study, and they were evaluated based on their titles, abstracts, and complete texts and. Result: Eight studies (three cross-sectional articles and five cohort articles) involving 147,601 participants from Japan, China, Korea, and the United States were included. The results of this study showed that weight loss had significantly increased odds of developing NAFLD independently and per 1 kg compared to the stable weight control group. (OR = 1.16, 95% CI: 1.118–1.208, p < 0.0001, I2 = 86%, OR = 1.186, 95% CI: 1.142–1.230, p < 0.0001, I2 = 89.2%). The findings of seven articles indicated that the odds of experiencing NAFLD among patients with increased weight was 0.697 (OR = 0.697, 95% CI: 0.391–1.002, p < 0.0001, I2 = 99.9%), suggesting a slightly reduced likelihood compared to the control group. The sensitivity analysis supported the robustness of the findings. Conclusion: Nonalcoholic fatty liver disease is increasing in industrialized nations and has a significant financial impact on people′s health and healthcare systems. It can be controlled by emphasis on reducing weight change and maintaining a healthy weight. © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. The Effects of Weight Loss Interventions on Children and Adolescents With Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis, Obesity Science and Practice (2024)
2. Dietary Inflammatory Index and Non-Alcoholic Fatty Liver Disease Risk: A Systematic Review and Meta-Analysis of Observational Studies, Frontiers in Nutrition (2025)
3. Efficacy of Orlistat for the Treatment of Metabolic Dysfunction–Associated Steatotic Liver Disease Patients: A Systematic Review and Meta-Analysis, Hepatology Forum (2025)
Experts (# of related papers)
View all Related Experts
Pejman Rohani (2)
Hossein Poustchi (1)
Other Related Docs
4. What Are the Effects of N-Acetylcysteine Supplementation on Anthropometric Indices? a Systematic Review and Meta-Analysis of Clinical Trials, PharmaNutrition (2020)
5. Obesity As an Independent Risk Factor for Covid-19 Severity and Mortality, Cochrane Database of Systematic Reviews (2023)
6. Which Dietary Patterns Fend Off Nonalcoholic Fatty Liver Disease? a Systematic Review of Observational and Interventional Studies, BMC Nutrition (2024)
7. Intake of Nutrients, Fiber, and Sugar in Patients With Nonalcoholic Fatty Liver Disease in Comparison to Healthy Individuals, International Journal of Preventive Medicine (2016)
8. Investigating the Relationship Between Insulin Resistance and Fatty Liver in a Random Population of Tehran, Hepatitis Monthly (2020)
9. Green Cardamom Increases Sirtuin-1 and Reduces Inflammation in Overweight or Obese Patients With Non-Alcoholic Fatty Liver Disease: A Double-Blind Randomized Placebo-Controlled Clinical Trial, Nutrition and Metabolism (2018)
10. Dietary Insulin Index and Dietary Insulin Load in Relation to Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study, Public Health Nutrition (2024)
11. The Effect of Nigella Sativa Supplementation on Cardiometabolic Health in Patients With Metabolic Diseases: A Grade-Assessed Systematic Review and Meta-Analysis, Endocrinology, Diabetes and Metabolism (2026)
12. The Association Between Metabolic-Associated Fatty Liver Diseases and Risk of Colorectal Polyps, Neoplasia, and Cancer: A Systematic Review and Meta-Analysis of Over 56 Million Individuals, Clinics and Research in Hepatology and Gastroenterology (2025)
13. Impact of Standard Treatment on the Quality of Life of Non-Alcoholic Fatty Liver Disease Patients, Journal of Taibah University Medical Sciences (2021)
14. Nano-Curcumin Improves Glucose Indices, Lipids, Inflammation, and Nesfatin in Overweight and Obese Patients With Non-Alcoholic Fatty Liver Disease (Nafld): A Double-Blind Randomized Placebo-Controlled Clinical Trial, Nutrition and Metabolism (2019)
15. The Relationship Between Anthropometric Indices and Non-Alcoholic Fatty Liver Disease in Adults: A Cross-Sectional Study, Frontiers in Nutrition (2024)
16. Low Fat-Diet and Circulating Adipokines Concentrations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Diabetology and Metabolic Syndrome (2025)
17. Impact of Gluten-Free Diet on Anthropometric Indicators in Individuals With and Without Celiac Disease: A Systematic Review and Meta-Analysis, Clinical Therapeutics (2023)
18. The Association of Fructose and Fiber Consumption and Physical Activity With Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Cross-Sectional Study, BMC Nutrition (2024)
19. Association of Nonalcoholic Fatty Liver Disease and Carotid Media-Intima Thickness: A Systematic Review and a Meta-Analysis, Health Science Reports (2023)
20. The Effect of Synbiotic Supplementation on Body Composition and Lipid Profile in Patients With Nafld: A Randomized, Double Blind, Placebo-Controlled Clinical Trial Study, Iranian Red Crescent Medical Journal (2017)